Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,910 | 2,816 | 2,564 | 0 | 2,600 |
| Cost of Goods | 1,469 | 1,596 | 1,535 | N/A | 1,238 |
| Gross Profit | 1,441 | 1,220 | 1,029 | N/A | 1,362 |
| Operating Expenses | 3,286 | -1,000 | 3,838 | 0 | 2,362 |
| Operating Income | -1,376 | -1,635 | -2,274 | N/A | -766 |
| Other Income | 29 | 1,635 | 31 | 0 | 25 |
| Pre-tax Income | -1,347 | 0 | -2,243 | 0 | -741 |
| Net Income Continuous | -1,347 | N/A | -2,243 | N/A | -741 |
| Net Income | $-1,347 | $N/A | $-2,243 | $N/A | $-745 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.20 | N/A | -0.10 |
| EPS Basic Continuous Ops | -0.09 | N/A | -0.16 | N/A | -0.06 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.20 | N/A | -0.10 |
| EPS Diluted Continuous Ops | -0.09 | N/A | -0.16 | N/A | -0.06 |
| EBITDA(a) | $-1,304 | $2,288 | $-2,274 | $N/A | $-632 |